Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Opus Genetics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 37 | −11 |
| Shares | 3.37M | 5 | 2.70M | −678.2K (−20.1%) |
| Value | $6.78M | $10 | $4.13M | −$2.65M (−39.2%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Opus Genetics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 42,375 | $64.8K | 0.00% |
| Bank of America Corp | 213 | $326 | 0.00% |
| Group One Trading, L.P. | 76 | $116 | 0.00% |
Sold out (14)
Institutions that held Opus Genetics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| MAI Capital Management | 223,970 | $450.2K |
| American Century Companies Inc | 65,911 | $132.5K |
| Mackenzie Financial Corp | 40,814 | $82.0K |
| Millennium Management LLC | 36,628 | $73.6K |
| HRT Financial LP | 19,868 | $39.0K |
| Virtu Financial LLC | 17,752 | $36.0K |
| Prudential Financial Inc | 17,400 | $35.0K |
| Lincoln National Corp | 11,900 | $23.9K |
| Summit Trail Advisors, LLC | 10,545 | $21.2K |
| Toth Financial Advisory Corp | 1,001 | $2.01K |
| Optimum Investment Advisors | 1,000 | $2.01K |
| Old Point Trust & Financial Services N A | 500 | $1.00K |
| NBC Securities, Inc. | 600 | $1.00K |
| ICA Group Wealth Management, LLC | 10 | $20 |
Not filed for Q2 2024 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| FSA Wealth Management LLC | 5 | $10 |